Casdin Capital

company

Investments

Number of Investments
Number of Lead Investments
34
8
Casdin Capital has made 34 investments. Their most recent investment was on Mar 17, 2022, when Deepcell, Inc raised
Date Company Name Round Money Raised Industry Lead Investor
Mar 17, 2022 Deepcell Series B Artificial Intelligence
Nov 29, 2021 Lunit Series Unknown Artificial Intelligence
Oct 7, 2021 Science 37 Post-IPO Equity Biotechnology
Sep 1, 2021 SomaLogic Post-IPO Equity Biotechnology
Jul 20, 2021 TMRW Life Sciences Series C Biotechnology
Jul 13, 2021 Prime Medicine Series B Biotechnology
May 5, 2021 NeoGenomics Post-IPO Equity Biotechnology
Apr 27, 2021 Treeline Biosciences Series A Biotechnology
Mar 23, 2021 Absci Series Unknown Artificial Intelligence Yes
Mar 22, 2021 Komodo Health Series E Health Care
Mar 1, 2021 Tenaya Therapeutics Series C Biopharma
Feb 5, 2021 Imagen Technologies Series C Artificial Intelligence Yes
Jan 19, 2021 Beam Therapeutics Post-IPO Equity Biotechnology
Jan 19, 2021 Verve Therapeutics Series B Biotechnology Yes
Jan 14, 2021 Paige Series C Artificial Intelligence Yes
Jan 7, 2021 Scorpion Therapeutics Series B Biotechnology
Nov 25, 2020 SomaLogic Series A Biotechnology Yes
Oct 20, 2020 Absci Series E Artificial Intelligence Yes
Oct 13, 2020 Oxford Nanopore Technologies Series H Biopharma
Oct 6, 2020 A2 Biotherapeutics Series B Biotechnology
Jun 11, 2020 Verve Therapeutics Series A Biotechnology
Jan 11, 2020 PACT Pharma Series C Biotechnology
Oct 3, 2019 Tenaya Therapeutics Series B Biopharma Yes
Aug 9, 2019 ORIC Pharmaceuticals Series D Biotechnology
Jun 20, 2019 Codexis Post-IPO Equity Biotechnology Yes
Jan 9, 2019 Black Diamond Therapeutics Series B Biotechnology
Sep 7, 2018 Imagen Technologies Series B Artificial Intelligence
May 25, 2018 PACT Pharma Series B Biotechnology
Jan 15, 2018 Genapsys Series C Bioinformatics
Oct 27, 2017 Helix Series Unknown Big Data
Nov 12, 2014 Blueprint Medicines Series C Bioinformatics
Oct 13, 2014 Invitae Series F Biotechnology
Jan 7, 2014 Blueprint Medicines Series B Bioinformatics
Dec 10, 2013 Invitae Series E Biotechnology